The Liver Meeting

Healio brings you the highlights from The Liver Meeting. Refer back to this page often for the latest news from The Liver Meeting, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News

Combined ruzasvir, uprifosbuvir shows suboptimal HCV pangenotypic efficacy

November 8, 2017
WASHINGTON — The combination of Merck’s ruzasvir and uprifosbuvir correlated with reduced efficacy in patients with hepatitis C genotype…
Meeting NewsVideo

VIDEO: Reduce HCV reinfection in drug users with strategic care

October 31, 2017
WASHINGTON — In this exclusive video from The Liver Meeting 2017, Gregory J. Dore, MBBS, PhD, FRACP, MPH, from the Kirby Institute at the…
Meeting NewsVideo

VIDEO: Obeticholic acid decreases alkaline phosphatase in PSC

October 27, 2017
WASHINGTON, D.C. — In this exclusive video from The Liver Meeting 2017, Kris V. Kowdley, MD, FAASLD, of the Swedish Medical Center, Liver Care…
Meeting News

ITCH study shows reduction in pruritus in Alagille syndrome

October 27, 2017
WASHINGTON — In a dose-varied study of maralixibat, patients’ caregivers reported trends toward pruritis relief while the drug also…
Meeting NewsVideo

VIDEO: Microbiota composition, functionality normalizes after liver transplant

October 26, 2017
WASHINGTON — In this exclusive video from The Liver Meeting 2017, Jasmohan S. Bajaj, MD, from the Virginia Commonwealth University in…
Meeting News

Maralixibat relieves pruritus, reduces serum bile acid

October 26, 2017
WASHINGTON — Maralixibat, a minimally absorbed inhibitor of the ileal apical sodium-dependent bile acid transporter, provided long-term relief…
Meeting News

New three-drug HCV regimen shows nearly 100% response in 6, 8 weeks

October 26, 2017
WASHINGTON — A novel triple therapy combination correlated with nearly perfect SVR12 rates in most patients treated for 6 or 8 weeks, according…
Meeting NewsVideo

VIDEO: Expert reviews promising treatment data from The Liver Meeting 2017

October 25, 2017
WASHINGTON, D.C. — In this exclusive video from The Liver Meeting 2017, Kris V. Kowdley, MD, FAASLD, of the Swedish Medical Center, Liver Care…
Meeting News

Novel enzyme inhibitor improves hepatic steatosis in NASH

October 25, 2017
WASHINGTON — Treatment with a novel acetyl-CoA carboxylase inhibitor significantly improved hepatic steatosis and selected fibrosis markers in…
Meeting NewsVideo

VIDEO: Alcohol misuse, related cirrhosis increasing in U.S.

October 25, 2017
WASHINGTON — In this exclusive video from The Liver Meeting 2017, Jessica L. Mellinger, MD, from the department of Internal…

Meeting Calendar

The Liver Meeting

October 20, 2017 - October 24, 2017

  • Location: Washington, D.C.
  • Website
Advertisement
Advertisement